NCT07493902 Acupuncture for Post-Stroke Dysphagia: A Clinical Study
| NCT ID | NCT07493902 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Teaching Hospital of Tianjin University of Traditional Chinese Medicine |
| Condition | Post-stroke Dysphagia |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,232 participants |
| Start Date | 2026-04 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,232 participants in total. It began in 2026-04 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Employing a nested design, a partially randomized preference study (Study II) is embedded within a prospective, multicenter cohort study (Study I). The cohort study, with acupuncture as the exposure factor, explores the clinical efficacy and health economic value of different integrated Chinese and Western medicine treatment protocols. The nested partially randomized preference study of different acupuncture protocols generates high-level evidence through randomized cohorts while supplementing real-world decision-making with preference cohort data.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 80 years old, no gender restrictions; * Meets diagnostic criteria for ischemic or hemorrhagic stroke, confirmed by CT or MRI, with disease duration within one year; * Meets diagnostic criteria for dysphagia, with FOIS grade 2-4; * Vital signs stable, able to understand and cooperate with study procedures; ⑤ Patient or legal representative agrees to sign informed consent. Exclusion Criteria: * Dysphagia not caused by stroke, but resulting from other neurological disorders (e.g., motor neuron disease, myasthenia gravis) or organic lesions (e.g., tumors); * Patients with psychiatric disorders or severe cognitive impairment who cannot cooperate with treatment; * Patients with an expected survival time of less than 3 months; ④ Individuals with contrast medium allergy; * Patients with severe needle phobia who cannot tolerate the procedure; ⑥ Pregnant women, those planning pregnancy, or lactating women; ⑦ Individuals who have participated in other clinical trials or received acupuncture within the past week.
Frequently Asked Questions
Who can join the NCT07493902 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Post-stroke Dysphagia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07493902 currently recruiting?
Yes, NCT07493902 is actively recruiting participants. Visit ClinicalTrials.gov or contact First Teaching Hospital of Tianjin University of Traditional Chinese Medicine to inquire about joining.
Where is the NCT07493902 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07493902 clinical trial?
NCT07493902 is sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. The trial plans to enroll 3,232 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.